Catalogo dei Corsi di studio

Curriculum breve Jessica Pepe
Istruzione e formazione:
-Idoneità all abilitazione nazionale per professori seconda fascia settore 06/B1 (luglio 2017)
-Dottorato di ricerca in Fisiopatologia e clinica dell apparato scheletrico , Università di Roma Sapienza (2013)
-Specializzazione in medicina interna II° Scuola di Medicina Interna, Università di Roma Sapienza con votazione di 70/70 e lode (2006)
-Laurea in medicina e chirurgia, Università di Roma Sapienza , votazione 110/ 110 e laude (2001)

Esperienza lavorative:
- Ricercatore di tipo B (RDTB), presso il Dipartimento di Scienza Cliniche, Internistiche, Anestesiologiche e Cardiovascolari (2020-oggi)
-Ricercatore di tipo A (RDTA), presso il Dipartimento di Scienza Cliniche, Internistiche, Anestesiologiche e Cardiovascolari (2018-2020)
-Assegnista di ricerca, presso il Dipartimento di Medicina Interna e Specialità Mediche (2015-2018)
-Contratto co.co.co presso il Dipartimento di Medicina Interna e Specialità Mediche (2013-2014)
-Contratto co.co.co presso il Dipartimento di Medicina Interna e Specialità Mediche (luglio-nov.2009)
-Medico di pronto soccorso presso il DEA del Policlinico Umberto I, Rome (maggio 2008-luglio 2009)
-Medico di pronto soccorso presso il DEA Ospedale S. Eugenio, Roma (marzo 2008-maggio 2008)
-Medico di pronto soccorso presso il Pronto soccorso Nuovo Regina Margherita, Roma (lug. 2007-Feb 2008)

Esperienze all estero:
- Service of Bone Diseases of the Geneva University Hospital, Switzerland (aprile 2015- aprile 2016)
- George Washington University Medical Center, Department of Internal Medicine, Division of Cardiology, DC, USA (aprile-maggio 2006)

Didattica:
-Docenza di Medicina interna e chirurgia I, V anno, corso di laurea in medicina e chirurgia A, Facoltà di Medicina e Odontoiatria, Sapienza , Roma (2018-oggi)
- Docenza di Medicina interna e chirurgia III, VI anno, corso di laurea in medicina e chirurgia A, Facoltà di Medicina e Odontoiatria, Sapienza , Roma (2019-oggi)
- Docenza di Metodologia medico-scientifica clinica I, III anno, corso di laurea in medicina e chirurgia A, Facoltà di Medicina e Odontoiatria, Sapienza , Roma (2020-oggi)
- Docenza di Metodologia medico-scientifica clinica II, III anno corso di laurea in medicina e chirurgia D, Facoltà di Medicina e Odontoiatria, Sapienza , Roma (2019-oggi)
- Docenza di Metodologia medico-scientifica pre-clinica, II anno corso di laurea in medicina e chirurgia B, Facoltà di Medicina e Odontoiatria, Sapienza , Roma (2019-oggi)

Associated editor nell Editorial board:
-Journal of Endocrinological Investigation (dal 2017-oggi)
-Aging Clinical and Experimental Research (dal 2019-oggi)
-Bone reports (dal 2021-oggi)
-Nutrients (dal 2020-oggi)
-Review Editor on the Editorial Board of Molecular Medicine (specialty section of Frontiers in Cell and Developmental Biology) (dal 2021-oggi)

Attività in società scientifiche nazionali e internazionali

2018-2020 membro del Clinical action group dell ECTS, commissione con ruolo di scrivere Position Statement della società scientifica
2021-oggi membro del ECTS E-learning action group, commissione con ruolo di organizzare webinar didattici per la società scientifica
2022 commissione scientifica SIOMMMS
2022 Commissione didattico formativa SIMI

Premi:
- Premio per Best Poster Presentation al 114 Congresso della SIMI (2013)
- Premio Best oral Poster Presentation al 118 Congresso della SIMI (2017)
-Premio Best oral Poster Presentation al 119 Congresso della SIMI (2018)
-Premio Best reviewer per la rivista Journal of endocrinological investigation (2019)

Vincitore di fondi per progetti di ricerca:
-come primo investigatore: Premio Condorelli SIMI (2016), per un giovane ricercatore all estero SIOMMMS (2014)
- premio di ricerca FEDIOS (2015)
-come co -investigatore bandi Sapienza progetti medi (2012,2013,2015-2020) e prin 2015

Pubblicazioni::
1 Anastasilakis AD, Pepe J, Napoli N, Palermo A,Magopoulos C, Khan AA, Zillikens MC, Body JJ.Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by ECTS.J Clin Endocrinol Metab. 2021: dgab888. Online ahead of print.
2.De Martino V, Rossi M, Battafarano G, Pepe J, Minisola S, Del Fattore A. Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents? Int J Mol Sci. 2021 ;22(22):12586
3.Paccou J, Tsourdi E, Meier C, Palermo A, Pepe J, Body JJ, Zillikens MC.Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS). Bone 2022; 154:116236.
4. Minisola S, De Martino V, Cipriani C, Pepe J, Colangelo L, Sonato C Vitamin D3 and 25(OH)D3: an open debate.Am J Clin Nutr. 2021;114(3):1251.
5.Pepe J, Bonnet N, Cipriani C, Ferrara C, Rossi M, De Martino V, Colangelo L, Sonato C, Cecchetti V, Ferrari S, Minisola S Higher serum levels of a cathepsin K-generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot study.Osteoporos Int. 2021, 32(11):2365-2369 .
6.Cipriani C, Minisola S, Colangelo L, DE Martino V, Ferrone F, Biamonte F, Danese V, Sonato C, Santori R, Occhiuto M, Pepe J. FGF23 functions and disease. Minerva Endocrinol (Torino). 2021 Apr 1. doi: 10.23736/S2724-6507.21.03378-2. Online ahead of print.
7. Pepe J, Sonato C, Colangelo L, Minisola S, Cipriani C. Challenges in Diagnosing of Normocalcemic Primary Hyperparathyroidism. Endocr Pract. 2021;27(6): 644.
8. Pepe J, Della Grotta G, Santori R, De Martino V, Occhiuto M, Cilli M, Minisola S, Cipriani C Lumbar spine bone mineral density and trabecular bone score-adjusted FRAX, but not FRAX without bone mineral density, identify subclinical carotid atherosclerosis.J Endocrinol Invest. 2021;44(9):1989-1995.
9.Cipriani C, Minisola S, Bilezikian JP, Diacinti D, Colangelo L, Piazzolla V, Angelozzi M, Nieddu L, Pepe J, Diacinti D.Vertebral Fracture Assessment in Postmenopausal Women With Postsurgical Hypoparathyroidism.J Clin Endocrinol Metab. 2021 23;106(5):1303-1311.
10.Minisola S, Colangelo L, Pepe J, Diacinti D, Cipriani C, Rao SD.Osteomalacia and Vitamin D Status: A Clinical Update 2020.JBMR Plus. 2020 Dec 21;5(1):e10447.
11.Diacinti D, Cipriani C, Biamonte F, Pepe J, Colangelo L, Kripa E, Iannacone A, Orlandi M, Guarnieri V, Diacinti D, Minisola S Imaging technologies in the differential diagnosis and follow-up of brown tumor in primary hyperparathyroidism: Case report and review of the literature. Bone Rep. 2020;14:100745.
12.Pepe J, Colangelo L, Sonato C, Occhiuto M, Ferrara C, Del Fattore A, Santori R, Mastrantonio M, Sgreccia A, Minisola S, Cipriani C. Echocardiographic findings in patients with normocalcemic primary hyperparathyroidism compared with findings in hypercalcemic primary hyperparathyroid patients and control subjects. Endocr Pract. 2021;27(1):21-26
13. Minisola S, Pepe J, Cipriani C. Rheumatoid arthritis, bone and drugs: a dangerous interweave. Ann Rheum Dis. 2021annrheumdis-2020-219545.
14.Pepe J, Agosti P, Cipriani C, Tettamanti M, Nobili A, Colangelo L, Santori R, Cilli M, Minisola S; Reposi investigators. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register). Endocrine. 2021;71(2):484-493.
15.Tsourdi E, Zillikens C, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N,Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B. Characterization of fracture risk and management of discontinuation of denosumab therapy for osteoporosis: a systematic review and updated position statement by European Calcified Tissue Society (ECTS). JCEM 2020 26:dgaa756.
16.Cipriani C, Piemonte S, Colangelo L, De Martino V, Diacinti D, Ferrone F, Piazzolla V, Fassino V, Nieddu L, Minisola S, Pepe J Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study. Endocrine. 2020 Online ahead of print.
17. Pepe J, Body JJ, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, Palermo A, Tsourdi E, Zillikens MC, Langdahl B, Ferrari S Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa306
18.Diacinti D, Pisani D, Cipriani C, Celli M, Zambrano A, Diacinti D, Kripa E, Iannacone A, Colangelo L, Nieddu L, Pepe J, Minisola S.Vertebral Fracture Assessment (VFA) for monitoring vertebral reshaping in children and adolescents with Osteogenesis Imperfecta treated with intravenous neridronate. Bone. 2020
19.Pepe J, Colangelo L, Biamonte F, Sonato C, Danese VC, Cecchetti V, Occhiuto M, Piazzolla V, De Martino V, Ferrone F, Minisola S, Cipriani C. Diagnosis and management of hypocalcemia. Endocrine. 2020; 69(3):485-495
20.S Minisola, C Cipriani, J Pepe Skeletal protection in patients with primary hyperparathyroidism The Lancet Diabetes & Endocrinology 2020; 8 (5), 352-353S.
21.Minisola S, L. Colangelo,J. Pepe,M. Occhiuto,V. Piazzolla, M. Renella,F. Biamonte,C. Sonato, M. Cilli , C Cipriani. Vitamin D screening. JEI, 2020; 43(8):1047-1051
22. L Colangelo, J Pepe, L Nieddu, C Sonato, A Scillitani, D Diacinti, M Angelozzi, C Cipriani, S Minisola. Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia.Osteoporosis international 2020; 31(7):1383-1387
23.Cipriani C, Colangelo L, Santori R, Renella M, Mastrantonio M, Minisola S, Pepe J. The interplay between bone and glucose metabolism. Frontiers in Endocrinology, 2020; 11:122. doi: 10.3389/fendo.2020.00122
24.Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S, Pepe J. Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol. 2020 8(2):163-174
25.S Minisola, C Cipriani, G Della Grotta, L Colangelo,M Occhiuto, P Biondi, C Sonato, E Vigna, M Cilli , J Pepe Update on the safety and efficacy of teriparatide in the treatment of osteoporosis. Therapeutic Advances in Musculoskeletal Disease, 2019, 11:1759720X19877994
26.Rossi M, Battafarano G, Pepe J, Minisola S, Del Fattore A.The Endocrine Function of Osteocalcin Regulated by Bone Resorption: A Lesson from Reduced and Increased Bone Mass Diseases.Int J Mol Sci. 2019;20(18). pii: E4502
27.Minisola S, Colangelo L, Cipriani C, Pepe J. FGF 23 and trabecular microarchitecture. Osteoporos Int. 2019, 30(11):2357
28.Cipriani C, Pepe J, Colangelo L, Fassino V, Occhiuto M, Biondi P, Nieddu L, Minisola S. Investigating subtle kidney injury in primary hyperparathyroidism by means of sensitive and specific biomarkers.Clin Endocrinol (Oxf). 2019 91(5):660-668
29.Anastasilakis AD, Tsourdi E, Makras P, Polyzos SA, Meier C, McCloskey EV, Pepe J, Zillikens MC.Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society. Bone. 2019 127:401-418
30.Ferrone F, Pepe J, Danese VC, Fassino V, Cecchetti V, De Lucia F, Biamonte F, Colangelo L, Ferrazza G, Panzini E, Scillitani A, Nieddu L, Blocki F, Rao SD, Minisola S, Cipriani C.The relative influence of serum ionized calcium and 25-hydroxyvitamin d in regulating pth secretion in healthy subjects. Bone 2019;125:200-206
31.Pepe J, et al.Patients' reasons for adhering to long-term alendronate therapy.Osteoporos Int. 2019 30(8):1627-34
32.Donato P, Pepe J, Colangelo L, Danese V, Cecchetti V, Minisola S, Cipriani C.Adherence to bisphosphonates in the general population: a study in patients referred to a primary care service. Arch Osteoporos. 2019;14(1):42.
33.L Colangelo, F Biamonte, J Pepe, C Cipriani, S Minisola Understanding and managing secondary osteoporosis. Expert Review of Endocrinology & Metabolism 2019;14(2):111-122
34.Minisola S, Ferrone F, Danese V, Cecchetti V, Pepe J, Cipriani C, Colangelo L. Controversies Surrounding Vitamin D: Focus on Supplementation and Cancer. Int J Environ Res Public Health. 2019;16(2).
35.S Minisola, C Cipriani, L Colangelo, F Biamonte, J Pepe. Serum Calcium Values and Refractory Vasodilatory Shock. Chest 2019,155 (1): 242
36.Minisola S, Colangelo L, Cipriani C, Pepe J, Cook DP, Mathieu C. DEBATE: Screening for hypovitaminosis D: cost-effective or not? Eur J Endocrinol. 2019 180(3): D1-D7
37. Pepe J, Cipriani C, Tedeschi M, Curione M, Parravano M, Varano M, Biamonte F, Colangelo L, Minisola S.Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism. Sci Rep. 2018;8(1):16521
38.E Biver, J Pepe, A de Sire, T. Chevalley, Ferrari S. Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women. Osteop Int, 2019;30(2):411-421
39. Cipriani C, Pepe J, Silva BC, Rubin MR, Cusano NE, McMahon DJ, Nieddu L, Angelozzi M, Biamonte F, Diacinti D, Hans D, Minisola S, Bilezikian JP. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.JBMR 2018;33(12):2132-2139
40. Chiodini I, Cairoli E, Palmieri S, Pepe J, Walker MD. Non classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):805-820
41.S Minisola, J Pepe, P Donato, E Vigna, M Occhiuto, F Ferrone, F Biamonte,V Cecchetti, V C Danese, C Sonato, P Biondi, L Colangelo, C Cipriani. Replenishment of vitamin D status: theoretical and practical considerations. Hormones 2019;18(1):3-5.
42.Pepe J, et al. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24 hour ecg monitoring. Eur J Endocrinol 2018; 179 (2): 117-124
43.Cipriani C, Pepe J, Minisola S, Lewiecki EM Adverse effects of media reports on the treatment of osteoporosis. JEI 2018 41(12):1359-1364
44. Argirò R, Diacinti D, Sacconi B, Iannarelli A, Diacinti D, Cipriani C, Pisani D, Romagnoli E, Biffoni M, Di Gioia C, Pepe J, Bezzi M, Letizia C, Minisola S, Catalano C. Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans. Eur Radiol. 2018 ;28(11):4900-4908
45. L Colangelo, C Cipriani, J Pepe, A Corsi, C Sonato, G Follacchio, M Cilli, W Gianni, F Ferrone,O Moreschini, L A Fitzpatrick,·S Minisola.A challenging case of tumor induced osteomalacia: pathophysiological and clinical implications. Calcif Tissue Int. 2019, 103(4):465-468
46.Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, Minisola S, Cipri C, Vescini F, Scillitani A, Salcuni A, Palmieri S, Eller-Vainicher C, Chiodini I, Madeo B, Kara E, Castellano E, Borretta G, Gianotti L, Romanelli F, Camozzi V, Faggiano A, Corbetta S, Cianferotti L, Brandi ML, De Feo ML, Palermo A, Vezzoli G, Maino F, Scalese M, Marcocci C.Clinical presentation and management of patients with primary hyperparathyroidism in Italy. JEI 2018;41(11):1339-1348
47.Cianferotti L, Parri S, Gronchi G, Marcucci G, Cipriani C, Pepe J, Raglianti M, Minisola S, Brandi ML.Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database. Calcif Tissue Int. 2018;103(2):144-150.
48.Biamonte F, Rao SD, Cipriani C, Pepe J, Biondi P, Minisola S.Multiple Vertebral Osteonecroses (K mmell's Disease) After 10 Years on Denosumab: Is Osteocyte Apoptosis to Blame? More Evidence Needed.Calcif Tissue Int. 2018; 103(1):109-110
49.Minisola S, Cianferotti L, Biondi P, Cipriani C, Fossi C, Franceschelli F, Giusti F, Leoncini G, Pepe J, Bischoff-Ferrari HA, Brandi ML.Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens: response to comments by Chen et al. Osteoporos Int. 2018;29(5):1219-1220
50.Pepe J, Bonnet N, Herrmann FR, Biver E, Rizzoli R, Chevalley T, Ferrari SL.Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure. Osteoporos Int. 2018;29(2):339-346
51. Cipriani C, Pepe J, Bertoldo F, Bianchi G, Cantatore FP, Corrado A, Di Stefano M, Frediani B, Gatti D, Giustina A, Porcelli T, Isaia G, Rossini M, Nieddu L, Minisola S, Girasole G, Pedrazzoni M. The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study. JEI 2018;41(4):431-438
52.Pepe J, et al. Cardiovascular manifestations of primary hyperparathyroidism: a narrative review. Eur J Endocrinol, 2017, 177(6):R297-R308
53.Minisola S, Cianferotti L, Biondi P, Cipriani C, Fossi C,
Franceschelli F, Giusti F, Leoncini G, Pepe J, Bischoff-Ferrari H
A, Brandi M L.Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens. Osteop Int 2018 ,28:3239-3249
54.Biondi P, Pepe J, Biamonte F, Occhiuto M, Parisi M, Demofonti C, Baffa V, Minisola S, Cipriani C. Oral calcidiol is a good form of vitamin D supplementation.Clin Cases Miner Bone Metab 2017;14:207-208
55. Minisola S, Cipriani C, Occhiuto M, Pepe J. New anabolic therapies for osteoporosis. Internal and Emergency Medicine 2017; 12:915-921
56. Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT. Tumour-induced osteomalacia. Nat Rev Dis Primers. 2017;3:17044
57. Minisola F, Cipriani C, Colangelo L, Cilli M, Sciarra A, Von Heland M, Nieddu L, Anastasi E, Pascone R, Fassino V, Diacinti D, Longo F, Minisola S, Pepe J. Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study. Endocrine 2018; 59(2):338-343
58. Cipriani C, Pepe J, Clementelli C, Manai R, Colangelo L, Fassino V, Nieddu L, Minisola S.Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study. Br J Clin Pharmacol. 2017;83(10):2266-2273.
59.J Pepe, S Zawadynski, F R Herrmann , P Juillerat, P Michetti, S Ferrari-Lacraz , D Belli, O Ratib , R Rizzoli, T Chevalley , S L. Ferrari, Structural basis of bone fragility in young subjects with inflammatory bowel disease: a high resolution pQCT study of the SWISS IBD cohort (SIBDC).Inflammatory bowel disease 2017;23:1410-1417.
60.Pepe J, et al. The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis. JEI, 2017;40(6):663-667
61.Cipriani C, Pepe J, Biamonte F, Manai R, Biondi P, Nieddu L, Cianferotti L, Brandi ML, Minisola S.The Epidemiology of Hypoparathyroidism in Italy: An 8-Year Register-Based Study. Calcif Tissue Int. 2017;100(3):278-285
62.Pepe J, Biver E, Bonnet N, Herrmann FR, Rizzoli R, Chevalley T, Ferrari SL.Within and across-sex inheritance of bone microarchitecture. J Clin Endocrinol Metab. 2017;102(1):40-45.
63.Isidori AM, Cantisani V, Giannetta E, Diacinti D, David E, Forte V, Elia D, De Vito C, Sbardella E, Gianfrilli D, Monteleone F, Pepe J, Minisola S, Ascenti G, D'Andrea V, Catalano C, D'Ambrosio F. Multiparametric ultrasonography and ultrasound elastography in the differentiation of parathyroid lesions from ectopicthyroid lesions or lymphadenopathies. Endocrine 2017;57(2):335-343
64.Pepe J, et al. Adipokines and bone metabolism: an interplay to untangle. JEI 2016; 39(11):1359-1361
65.Pepe J, et al. High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score. Eur J Endocrinol 2016;175(2):95-100
66.Minisola S, Pepe J, Scillitani A, Cipriani C. Explaining geographical variation in the presentation of primary hyperparathyroidism. Lancet Diabetes Endocrinol. 2016; 4(8):641-3
67.Cipriani C, Piemonte S, Cilli M, Pepe J, Minisola S.Update on vitamin d: pros and cons. Clin Cases Miner Bone Metab. 2015;12(3):222-3
68.Minisola S, Cipriani C, Scillitani A, Pepe J. More on the use of bisphosphonates in the prevention and treatment of osteoporosis. BMJ 2015;351:h5868.
69. Minisola S, Cipriani C, Cilli M, Scillitani A, Pepe J. A reappraisal of vitamin D effect on non-skeletal targets and mortality. JEI 2015;38(11):1239-1241
70. Minisola S, Cipriani C, Diacinti D, Tartaglia F, Scillitani A, Pepe J, Scott-coombes D. Imaging of the parathyroid glands in primary hyperparathyroidism. Eur J Endocrinol 2016;174:D1-8.
71. Minisola S, Cipriani C, Pepe J. Parathyroid imaging and successful parathyroidectomy. Clin Endocrinol. 2015;83(5):616-617
72. Pepe J, et al. An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study. Endocrine 2016;53(1):299-304
73. Minisola S, Pepe J, Cipriani C. Authors' reply to Laurent. BMJ 2015 ;350:h3657.
74.Minisola S, Pepe J, Piemonte S, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ. 2015;350:h2723
75. Diacinti D, Pisani D, D'avanzo M, Celli M, Zambrano A, Stoppo M, Diacinti D, Roggini M, Todde F, D'eufemia P, Pepe J, Minisola S. Reliability of vertebral fractures assessment (vfa) in children with osteogenesis imperfecta. Calcif Tissue Int. 2015;96(4):307-312
76. Cipriani C, Biamonte F, Costa Ag, Zhang C, Biondi P, Diacinti D, Pepe J, Piemonte S, Scillitani A, Minisola S, Bilezikian Jp. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. JCEM 2015;100(4):1309-15.
77.Pepe J, et al. Emerging data on cardiovascular risk in primary hyperparathyroidism. Endocrine 2014;47(2):345-7
78.Cipriani C, Castro C, Curione M, Piemonte S, Biamonte F, Savoriti C, Pepe J, De Lucia F, Clementelli C, Nieddu L, Minisola S. Acute effect of zoledronic acid on the risk of cardiac dysrhythmias. Intern Emerg Med. 2015;10(2):151-6.
79.Minisola S, Pepe J, Cipriani C, Scillitani A, Piemonte S.Vitamin D: is evidence of absence, absence of evidence? Osteoporos Int. 2014; 25(10):2499-500
80.Cipriani C, Pepe J, Piemonte S, Colangelo L, Cilli M, Minisola S. Vitamin D and its relationship with obesity and muscle. Int J Endocrinol2014;2014:841248
81.Pepe J, Isidori Am, Falciano M, Iaiani G, Salotti A, Diacinti D, Del Fiacco R, Sbardella E, Cipriani C, Piemonte S, Raimo O, Biondi P, Biamonte F, Lenzi A, Minisola S.Effect of risedronate in osteoporotic hiv males, according to gonadal status: a pilot study. Endocrine 2014;47(2):456-62
82. Minisola, C Cipriani, S Piemonte, A Scillitani, J Pepe. Vitamin D: not all is bad. JEI 2014; 37(10):1015-6
83. Cipriani C, Carnevale V, Biamonte F, Piemonte S, Pepe J, Nieddu L, Bilezikian Jp, Minisola S. Hospital care for primary hyperparathyroidism in italy: a six-year register-based study. Eur J Endocrinol 2014;171(4):481-7
84. Minisola S, Cipriani C, Piemonte S, Colangelo L, Pepe J, Romagnoli E. Osteoprotegerin serum levels in primary hyperparathyroidism and changes following surgery. Horm Metab Res 2014;46(5):375
85.Cipriani C, Romagnoli E, Cilli M, Piemonte S, Pepe J, Minisola S. Quality of life in patients with primary hyperparathyroidism. Expert Rev Pharmacoecon Outcomes Res 2014;14(1):113
86.Piemonte S, Romagnoli E, Cipriani C, De Lucia F, Pilotto R, Diacinti D, Pepe J, Minisola S. Six years follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia. Eur J Endocrinol 2013;170(1):K1-4
87.Cipriani C, Romagnoli E, Carnevale V, Clerico R, Pepe J, Cilli M, Diacinti D, Savoriti C, Colangelo L, Minisola S. Effect of a single oral dose of 600,000 iu of cholecalciferol on muscle strength: a study in young women. JEI 2013;36(11):1051-4
88. Pepe J, et al. The effect of parathyroidectomy on chronic constipation in patients affected by primary hyperparathyroidism. J Bone Miner Metab. 2013;31(6):690-4
89. Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S. Value and limitations of assessing vitamin D nutritional status and advised levels of vitamin d supplementations. Eur J Endocrinol 2013;169(4):r59-69
90. Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, Nieddu L, Mcmahon Dj , Singh R, Minisola S. Long-term bioavailability after a single oral or intramuscular administration of 600,000 iu of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. Jcem 2013; 98: 2709-2715.
91. Pepe J,et al. parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism as evaluated by exercise test. Eur J Endocrinol 2013;169(2):255-261
92. Minisola S, Colangelo L, Cilli M, Cipriani C, Pepe J, Romagnoli E. intermittent high doses of vitamin d: a need for further studies? Calcif Tissue Int 2013 ;92(5):487-8.
93. Pepe J, et al. Arrhythmias in primary hyperparathyroidism evaluated by exercise test. Eur J Clin Invest 2013; 43(2) :208-214.
94. De Lucia F, Minisola S, Romagnoli E, Pepe J, Cipriani C, Scillitani A, Parikh N, Rao Ds.Effect of gender and geographic location on the expression of primary hyperparathyroidism. JEI 2013; 36 (2):123-126 .
95. Carnevale V, Del Fiacco R, Romagnoli E, Fontana A, Cipriani C, Pepe J, Minisola S. effects of strontium ranelate administration on calcium metabolism in female patients with postmenopausal osteoporosis and primary hyperparathyroidism. Calcif Tissue Int 2013;92(1):15-22
96.Romagnoli E, Cipriani C, Nofroni I, Castro C, Angelozzi M, Scarpiello A, Pepe J, Diacinti D, Piemonte S, Carnevale V, Minisola S. Trabecular bone score" (tbs): an indirect measure of bone microarchitecture in postmenopausal patients with primary hyperparathyroidism. Bone 2013;53(1):154-159.
97. Diacinti D, Del Fiacco R, Pisani D, Todde F, Cattaruzza Ms, Diacinti D, Arima S, Romagnoli E, Pepe J, Cipriani C, Minisola S. Diagnostic performance of vertebral fracture assessment by the lunar idxa scanner compared to conventional radiography. Calcif Tissue Int 2012;91(5):335-42
98.Pepe J, Isidori Am, Falciano M, Iaiani G, Salotti A, Diacinti D, Fiacco Rd, Sbardella E, Cipriani C, Piemonte S, Romagnoli E, Lenzi A, Minisola S. The combination of frax and aging male symptoms scale better identifies treated hiv males at risk for major fracture. Clin Endocrinol (Oxf) 2012;77(5):672-8.
99.Cipriani C, Romagnoli E, Carnevale V, Raso I, Scarpiello A, Angelozzi M, Tancredi A, Russo S, De Lucia F, Pepe J, Minisola S. Muscle strength and bone in healthy women: effect of age and gonadal status. Hormones (Athens) 2012;11(3):325-32
100.S Piemonte, E Romagnoli,C Bratengeier, W Woloszczuk, A Tancredi, J Pepe, C Cipriani, S Minisola Serum sclerostin levels decline in postmenopausal women with osteoporosis following treatment with intermittent pth. JEI 2012;35(9):866-8.
101. Ragno A, Pepe J, Badiali D, Minisola S, Romagnoli E, Severi C, D erasmo E. Chronic constipation in hypercalcemic patients with primary hyperparathyroidism. Eur Rev Med Pharmacol Sci 2012;16(7): 884-889.
102. Pepe J, et al. Sporadic and hereditary primary hyperparathyroidism. JEI 2011;34(7 suppl):40-4.
103. Russo S, Carlucci L, Cipriani C, Ragno A, Piemonte S, Fiacco Rd, Pepe J, Fassino V, Arima S, Romagnoli E, Minisola S. metabolic changes following 500 g monthly administration of calcidiol: a study in normal females. Calcif Tissue Int 2011;89(3):252-7.
104.Carnevale V, Romagnoli E, Del Fiacco R, Pepe J, Cipriani C, Piemonte S, Carlucci L, Minisola S Relationship between bone metabolism and adipogenesis. JEI 2010; 33(7 suppl):4-8.
105.Carnevale V, Romagnoli E, Cipriani C, Del Fiacco R, Piemonte S, Pepe J, Scillitani A, Minisola S. Sex hormones and bone health in males. Arch Biochem Biophys 2010 1;503(1):110-7.
106.Bruzzese V, Pepe J. Efficacy of cyclosporine in the treatment of a case of infliximab-induced erythrodermic psoriasis. Int J Immunopathol Pharmacol.2009;22(1):235-8
107.Bruzzese V, Pepe J. Unexpected and persistent depletion of b lymphocytes cd20 following a minimum dose of anti-cd20 antibody (rituximab). Reumatismo 2009;61(4):306-8.
108. Pepe J, Petrucci Mt, Mascia Ml, Piemonte S, Fassino V, Romagnoli E, Minisola S. The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance. Calcif Tissue Int 2008; 82(6):418-26
108.Minisola S, Pepe J, Romagnoli E. Monoclonal gammopathy of undetermined significance. NEJM 2007;356 (21): 2223-4
109.Pepe J, et al. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 2006;134:485-490
110.Carnevale V, Scillitani A, Vecci E, D Erasmo E, Romagnoli E, Paglia F, Pepe J, Baldini V, Santori C, De Geronimo S, Minisola S. Dehydroepiandrosterone sul fate and bone resorption rates as reflected by serum levels of c- terminal telopeptide of type i collagen: a study in healthy men. JEI 2005; 28(2):102-5
111.Pepe J, et al. Vitamin d status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 2005;16(7):805-812
112. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, Pepe J, Clemente G, Tonnarini G, Minisola S. Potential clinically utility of a new irma for parathyroid hormone in postmenopausal patients with primary hyper thyroidism. Clin. Chem 2004;50(3)626-31
113. Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J, Scillitani A, D' Erasmo E, Minisola S.Vitamin D status in female patients with primary hyperthyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf) 2004; 60(1):81-6
114. Romagnoli E, Carnevale V, Nofroni I, D Erasmo E, Paglia F, De Geronimo S, Pepe J, Raejentroph N, Maranghi M, Minisola S. Quality of life in ambulatory postmenopausal women impact of bone mineral density and subclinical vertebral fractures. Osteoporos Int 2005; 15(12) 975-80
115. Romagnoli E, Carnevale V, Calandra P, D' Erasmo E, De Geronimo S, Pepe J, Manfredi G, Maranghi M, Aliberti A, Minisola S. Impact fractures on health care in major university hospital in rome. Aging Clin Exp Res 2003;15(6):505-11
116.Romagnoli E, Paglia F, Dionisi S, De Geronimo S, Pepe J, Di Virgilio R, Minisola S. Male osteoporosis: current treatments and future options. Clin Ter 2003;154(1):49-53
117. Pepe J, et al. La sindrome di pendred. stato dell arte e contributo casistico. Il Policlinico 2002;109(7):345-49
118. Minisola S, Dionisi S, Pacitti Mt, Paglia F, Carnevale V, Scillitani A, Mazzaferro S, De Geronimo S, Pepe J, D erasmo E, Romagnoli E. Gender differences of serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos. Int 2002;13 (2):171-5
119. Dionisi S, Minisola S, Pepe J, De Geronimo S, Paglia F, Memeo L, Fitzpatrick La. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis. Mayo Clin Proc 2002;77(8):886-9
120. Minisola S, Rosso R, Romagnoli E, Pepe J, De Geronimo S, Dionisi S, Paglia F, Raejentroph N, Aliberti A, Mazzuoli G. Uneven deficits in vertebral bone density in postmenopausal patients with primary hyperparathyroidism as evaluated by posterior-anterior and lateral dual-energy absorbimetry. Osteoporos Int 2002;13(8):618-23
121. Romagnoli E, De Geronimo S, Pepe J, Dionisi S, Di Virgilio R, Paglia F, Minisola S. Clinical aspects of osteoporosis. Recenti Prog. Med 2002;93(9):484-8
122.Paglia F, Dionisi S, De Geronimo S, Rosso R, Romagnoli E, Raejntroph N, Ragno A, Celi M, Pepe J, D erasmo E, Minisola S. Biomarkers of bone turnover after a short period of steroid therapy in elderly men. Clin Chem 2001;47(7):1314-16

Capitoli di libri
1.J Pepe, S Minisola A Case with Postsurgical Hypoparathyroidism.Thyroid Cancer, 2016 Springer
2.Cipriani C, Pepe J, Colangelo L, Minisola S.Vitamin D and Secondary Hyperparathyroid States. Front Horm Res. 2018;50:138-148.
3.J Pepe, S Minisola A Case with Postsurgical Hypoparathyroidism.Thyroid Cancer, 2020 Springer
4.J Pepe, A Del Fattore, S Minisola, C Cipriani. Regulation of calcium and Phosphorous metabolism Handbook of Endocrinology and Metabolism for European Students Courses of Medicine and Biotechnology 2021